Nature Communications (May 2019)

JNK1/2 represses Lkb 1-deficiency-induced lung squamous cell carcinoma progression

  • Jian Liu,
  • Tianyuan Wang,
  • Chad J. Creighton,
  • San-Pin Wu,
  • Madhumita Ray,
  • Kyathanahalli S. Janardhan,
  • Cynthia J. Willson,
  • Sung-Nam Cho,
  • Patricia D. Castro,
  • Michael M. Ittmann,
  • Jian-Liang Li,
  • Roger J. Davis,
  • Francesco J. DeMayo

DOI
https://doi.org/10.1038/s41467-019-09843-1
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 16

Abstract

Read online

LKB1 is frequently mutated in lung squamous cell carcinomas. Here, the authors show that sole LKB1 depletion is sufficient to drive the development of this cancer, where downstream defective MKK7-JNK1/2 signalling activates the ∆Np63/p63 pathway to induce subsequent epithelial cells transformation and tumour progression.